Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
guidance
Pharma
Lilly sees big sales increase in 2026 despite pricing pressures
Eli Lilly has projected revenue of between $80 billion and $83 billion in 2026, which would be a 25% increase from 2025 sales at the midpoint.
Kevin Dunleavy
Feb 4, 2026 2:55pm
Organon hunts for new CEO after probe exposes sales misconduct
Oct 27, 2025 10:00am
Teva forecasts $5B-plus in innovative drug sales by 2030
May 30, 2025 7:20am
BMS accentuates the positive after Cobenfy trial flop
Apr 24, 2025 11:31am
J&J lifts 2025 sales guidance despite looming tariff threat
Apr 15, 2025 11:55am
WuXi AppTec offers rosy 2025 guidance despite US-China tensions
Mar 18, 2025 4:30pm
